A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate

Completed · Phase 3

Conditions studied: Osteoporosis

In brief

The purpose of this trial is to study the clinical safety, tolerability, and efficacy of zoledronic acid compared to an oral bisphosphonate in postmenopausal women with osteoporosis.

Key facts

Study ID
NCT00100555
Run by
Novartis Pharmaceuticals
People needed
120
Starts
2004-06-01
Expected to finish
2005-06-01
Last updated by the study team
2012-04-27

Who can join

Age: 45 and older, up to 79. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.